Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1998 Feb;78(2):169–171. doi: 10.1136/adc.78.2.169

Rifampicin and isoniazid prophylactic chemotherapy for tuberculosis

L Ormerod 1
PMCID: PMC1717463  PMID: 9579163

Abstract

Prophylaxis of tuberculosis in children with four month (n = 53) and three month regimens (n = 213) of rifampicin and isoniazid from 1987 to 1996 were tolerated without any toxicity. The reduction in the proportion of paediatric tuberculosis, which was seen after the introduction of chemoprophylaxis with longer regimens in 1981,was maintained with the shorter duration regimens. Altered immigration patterns and a fall in the proportion of infectious tuberculosis, as defined by sputum culture positivity, have been excluded as factors in the reduced paediatric proportion of tuberculosis. The data show such regimens have little toxicity and provide indirect evidence that three months chemoprophylaxis may be as effective as longer regimens. 



Full Text

The Full Text of this article is available as a PDF (66.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ormerod L. P., Horsfield N. Frequency and type of reactions to antituberculosis drugs: observations in routine treatment. Tuber Lung Dis. 1996 Feb;77(1):37–42. doi: 10.1016/s0962-8479(96)90073-8. [DOI] [PubMed] [Google Scholar]
  2. Ormerod L. P. Reduced incidence of tuberculosis by prophylactic chemotherapy in subjects showing strong reactions to tuberculin testing. Arch Dis Child. 1987 Oct;62(10):1005–1008. doi: 10.1136/adc.62.10.1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ormerod L. P. Tuberculosis screening and prevention in new immigrants 1983-88. Respir Med. 1990 Jul;84(4):269–271. doi: 10.1016/s0954-6111(08)80051-0. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES